January 2022 - Cancer Currents Blog
-
Cancer Immunotherapies Don’t Work for Everyone: HLA Gene May Explain WhyA specific form of the HLA gene, HLA-A*03, may make immune checkpoint inhibitors less effective for some people with cancer, according to an NCI-led study. If additional studies confirm the finding, it could help guide the use of these commonly used drugs.
-
Even If Insured, People with Advanced Cancer Often Face Financial ProblemsFinancial hardship caused by cancer care was common and occurred early in treatment, even for patients with insurance, a recent study found. The investigators believe financial hardship should be addressed like any other complication of cancer care.
-
Can mRNA Vaccines Help Treat Cancer?The success of mRNA vaccines for COVID-19 could help accelerate research on using mRNA vaccine technology to treat cancer, including the development of personalized cancer vaccines.
-
Should CAR T Cells Be Used Earlier in People with Non-Hodgkin Lymphoma?Results from three clinical trials have found that CAR T cells may be superior to standard treatments for patients with B-cell NHL that has not responded to treatment (refractory) or has returned after treatment (relapsed).
-
When Ovarian Cancer Returns, Surgery May Be a Good Choice for Selected PatientsFor patients with recurrent ovarian cancer who meet strict criteria, additional surgery may improve survival, results from a large clinical trial show.
-
FDA Oversight of E-Cigarettes Gathers Speed: A Conversation with Mitch ZellerCompanies that want to market e-cigarettes in the United States must now submit applications to the Food and Drug Administration (FDA). In this interview, Mitch Zeller, director of FDA’s Center for Tobacco Products, provides insights into FDA actions on e-cigarettes.